News - Appointments

Stewart Kay has joined UK-based Adaptate Biotherapeutics Ltd in the new role of chief business officer (CBO).

AM-Pharma BV has named Maarten Kraan as chief medical officer and Teun van de Laar as head of manufacturing and supply chain management.

Vaccitech Ltd has appointed three new senior leaders across its clinical, financial and manufacturing operations.

Karen Fallen has been appointed chief executive officer of Touchlight DNA Services Ltd, a biotechnology company focused on the discovery and development of DNA-based genetic medicines.

France-based Ipsen SA has appointed Philippe Lopes-Fernandes as chief business officer, effective 1 October, to manage its global specialty care business.

Cristina Csimma has become chair of the board of directors of Finland-based Forendo Pharma Ltd as the company advances development of its lead compound for endometriosis.

Julian Gough, co-founder and chief scientific officer of Mogrify Ltd, has received the Academic Entrepreneur of the Year award from Cambridge Enterprise, the commercialisation arm of the University of Cambridge.

Thomas Taapken, a senior manager with venture capital experience, has been named chief financial officer, effective 1 October, of InflaRx NV in Germany as the company starts a Phase 3 trial of its lead product for

UK-based Silence Therapeutics Plc has appointed Mark Rothera as president and chief executive officer to lead development of its prospective siRNA therapeutics.

Mariola Söhngen has joined Proteome Sciences Plc as a director and chief executive officer, taking over from the interim CEO Ian Pike who continues as chief scientific officer.